Double replacement: strategy for efficient introduction of subtle mutations into the murine Col1a-1 gene by homologous recombination in embryonic stem cells.
A subtle mutation that rendered type I collagen resistant to mammalian collagenase has been introduced into the murine Col1a-1 (recently redesignated Cola-1) gene by homologous recombination in embryonic stem (ES) cells. Initially, a "hit and run" procedure was used. Since two steps were required for introducing each mutation and more than one mutation was to be introduced in the same genomic region independently, we have developed a streamlined procedure that involves two sequential replacement-type homologous recombination events. In the first step, an internal deletion was introduced into the Col1a-1 locus along with the positive and negative selectable markers, neo and tk, to mark the region of interest. G418-resistant homologous recombinants were isolated and used in the second step in which the deleted Col1a-1 allele was replaced with a construct containing the desired mutation. Homologous recombinants containing the mutation were identified among the Tk- ES clones after selection with FIAU [1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodouracil (called fialuridine)]. Approximately 10% of such clones contained the desired mutation. The double replacement procedure greatly reduces the time and amount of work required to introduce mutations independently into the same or closely linked regions. Once the homologous recombinants derived from the first step are established, the introduction of other mutations into the deleted region becomes a one-step procedure. For X number of introduced mutations, 2X selections are required with the "hit and run" approach, but only X + 1 are required with the double-replacement method. This innovative procedure could be very useful in studies of gene structure and function as well as gene expression and regulation.
Wu
H
H
Whitehead Institute for Biomedical Research, Cambridge, MA 02142.
Liu
X
X
Jaenisch
R
R
D000818:Animals; D001086:Arabinofuranosyluracil / Q000031:analogs & derivatives / Q000494:pharmacology; D002478:Cells, Cultured; D003094:Collagen / Q000235:genetics* / Q000378:metabolism; D017364:Collagenases / Q000378:metabolism; D004622:Embryo, Mammalian / Q000166:cytology; D005822:Genetic Vectors; D051379:Mice; D016296:Mutagenesis; D017354:Point Mutation; D011995:Recombination, Genetic; D012641:Selection, Genetic; D013234:Stem Cells / Q000502:physiology*
D001086:Arabinofuranosyluracil; C043457:fialuridine; D003094:Collagen; D017364:Collagenases